VSIG4 and Acute hepatitis: In a in vivo model of concanavalin (ConA)-induced acute hepatitis, a down-regulation of SPECT signal of 99mTC-labeled anti-Vsig4 Nbs reflected a reduction in the number of KCs, indicating that Nbs targeting Vsig4 can be used as molecular marker to monitor KC dynamic modulation during hepatic inflammation [132].